Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models

BACKGROUND: Sulfasalazine (SSZ) is widely known as an xCT inhibitor suppressing CD44v9-expressed cancer stem-like cells (CSCs) being related to redox regulation. Cholangiocarcinoma (CCA) has a high recurrence rate and no effective chemotherapy. A recent report revealed high levels of CD44v9-positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanee, Malinee, Padthaisong, Sureerat, Suksawat, Manida, Dokduang, Hasaya, Phetcharaburanin, Jutarop, Klanrit, Poramate, Titapun, Attapol, Namwat, Nisana, Wangwiwatsin, Arporn, Sa-ngiamwibool, Prakasit, Khuntikeo, Narong, Saya, Hideyuki, Loilome, Watcharin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968252/
https://www.ncbi.nlm.nih.gov/pubmed/33726850
http://dx.doi.org/10.1186/s40170-021-00249-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968252/
https://www.ncbi.nlm.nih.gov/pubmed/33726850
http://dx.doi.org/10.1186/s40170-021-00249-6

Ejemplares similares